Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection

Ceftolozane/tazobactam, a cephalosporin–β-lactamase inhibitor combination, is approved for the treatment of complicated urinary tract infections and complicated intra-abdominal infections (cIAI). The safety and efficacy of ceftolozane/tazobactam in pediatric participants with cIAI were assessed. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Carl-Christian A., Newland, Jason, Dementieva, Nataliia, Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A., Bensaci, Mekki, Popejoy, Myra W., Johnson, Matthew G., De Anda, Carisa, Rhee, Elizabeth G., Bruno, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Antimicrobial Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259210/
https://www.ncbi.nlm.nih.gov/pubmed/37000942
http://dx.doi.org/10.1097/INF.0000000000003911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259210/
https://www.ncbi.nlm.nih.gov/pubmed/37000942
http://dx.doi.org/10.1097/INF.0000000000003911

Ejemplares similares